Accelerated Cardiomyopathy in Mice With Overexpression of Cardiac G s α and a Missense Mutation in the α-Myosin Heavy Chain
- 5 February 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (5) , 614-620
- https://doi.org/10.1161/hc0502.103012
Abstract
Background — To understand further the pathogenesis of familial hypertrophic cardiomyopathy, we determined how the cardiomyopathy induced by an Arg403→Gln missense mutation in the α-myosin heavy chain (403) is affected by chronically enhancing sympathetic drive by mating the mice with those overexpressing G s α (G s αx403). Methods and Results — Heart rate in 3-month-old conscious mice was elevated similarly ( P s α (G s α mice; 746±14 bpm) and G s αx403 mice (718±19 bpm) compared with littermate wild-type mice (WT; 623±18 bpm) and 403 mice (594±16 bpm). Left ventricular ejection fraction (LVEF), as determined by echocardiography, was enhanced in G s αx403 mice (88±1%, P s α (69±2%) mice. Isolated cardiomyocytes from G s αx403 mice also exhibited higher ( P s α (7.8±0.3%) cardiomyocytes. Relaxation of myocytes was impaired in 403 mice compared with WT but enhanced in G s α and normalized in G s αx403 mice. This was also observed in vivo. In vivo isoproterenol (0.1 μg · kg −1 · min −1 ) increased LVEF to maximal levels in G s αx403 and G s α, whereas in 403, the response was attenuated compared with WT. At 10 months of age, G s αx403 had significantly depressed LVEF (57±4%). Histopathological examination demonstrated that myocyte hypertrophy and fibrosis were already present in young G s αx403 mice and that old animals had severe cardiomyopathy. By 15 months of age, the survival of G s αx403 was 0% compared with 100% for WT, 71% for G s α, and 100% for 403 mice ( P Conclusions — These results show that the cardiomyopathy developed by G s αx403 mice is synergistic rather than additive, most likely owing to the elevated baseline function combined with enhanced responsiveness to sympathetic stimulation.Keywords
This publication has 13 references indexed in Scilit:
- The Genetic Basis for Cardiomyopathy: from Mutation Identification to Mechanistic ParadigmsPublished by Elsevier ,2001
- Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathyThe Lancet, 2000
- β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouseJournal of Clinical Investigation, 1999
- Differential regulation of inotropy and lusitropy in overexpressed Gsα myocytes through cAMP and Ca2+ channel pathwaysJournal of Clinical Investigation, 1999
- Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.Journal of Clinical Investigation, 1998
- A Mouse Model of Familial Hypertrophic CardiomyopathyScience, 1996
- Overexpression of Gs alpha protein in the hearts of transgenic mice.Journal of Clinical Investigation, 1995
- α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomereCell, 1994
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationPublished by Elsevier ,1990
- Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathyEuropean Heart Journal, 1983